Contract Research Organization WCCT Global Announces Attendance at ASCPT
WCCT Global Announces their attendance at the 1024 ASCPT Event at Booth #600
COSTA MESA, Calif., March 14, 2014 /PRNewswire-iReach/ — WCCT Global, a full-service CRO headquartered in Southern California announced today that they will be in attendance at the 2014 ASCPT event in Atlanta, Georgia. WCCT Global is pleased to be in attendance at this event because the company has expanded with multiple new service offerings including influenza challenge and ophthalmology research capabilities and an innovative patient recruitment process called “In-Site”. The influenza challenge unit is one of the newest additions to WCCT Global and is currently the only Influenza challenge facility in the United States. The new capabilities also include expanding their acquisition of their new ophthalmology and cosmetic research unit where they have the capabilities to run early and late phase ophthalmology clinical research. One of the most innovative service offerings is WCCT Global’s patient recruitment service called “In-Site”. This patient recruitment service is a new, proven model that allows WCCT Global to assist clients in selecting feasible sites based on patient accessibility proven from pharmacy data and other data sources. Also included in WCCT Global’s patient recruitment process is an innovative targeted advertising process to increase study timelines by optimizing all study advertising avenues. WCCT Global’s VP of Business Development stated,
“We are pleased to present our new service offerings at this year’s ASCPT because we feel we are truly a one-of-a-kind CRO that offers everything from site feasibility to study design and ultimately completion.”
For more information on WCCT Global:
WCCT Global is a multi-site, full-service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting-edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
If you are interested in how WCCT Global can service one of your upcoming clinical studies, CLICK HERE.
Media Contact: Matt Miller, WCCT Global, 714.668.1500 ext.2029, Matt.Miller@wcct.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE WCCT Global